Drug Development

(Image: Getty/masterzphotois)

How to reduce the odds of failure in late phase clinical trials

By Melissa Fassbender

Improving the prognostic value of early phase data is among one of several ways to increase the probability of successes in drug development, a process which has become more expensive as failure rates have risen, says an industry expert.

DIA 2019: 'The future is here'

DIA 2019: 'The future is here'

By Maggie Lynch

Live updates from the DIA Global Annual Meeting 2019 in San Diego as industry leaders from over 50 countries and 400 companies discuss the progress and innovations in drug product development.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers